Vanguard Asset Management
XERS icon

Vanguard Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Vanguard Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
133,417
+29,862
+29% +$191K ﹤0.01% 1853
2026
Q1 		$601K Buy
+103,555
New +$687K ﹤0.01% 2006

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Asset Management's XERS Position: Q2 2026 in Review

Vanguard Asset Management increased its Xeris Biopharma Holdings (XERS) stake by 29% in Q2 2026, buying an estimated $191K and bringing the position to 133,417 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

Vanguard Asset Management first reported a position in XERS in Q1 2026 and has held it in 2 quarters since. 217 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Vanguard Asset Management held 133,417 shares of Xeris Biopharma Holdings worth $1.06M as of Q2 2026.
  • Vanguard Asset Management bought 29,862 Xeris Biopharma Holdings shares in Q2 2026, an estimated $191K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1853 holding.
  • Vanguard Asset Management first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • 217 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.